Oculodentodigital dysplasia

Oculodentodigital dysplasia (ODDD), also known as oculodentodigital syndrome or Meyer-Schwickerath syndrome, is a rare genetic disorder that affects multiple body systems, most notably the eyes, teeth, and fingers. It is caused by mutations in the GJA1 gene, which encodes connexin 43, a gap junction protein essential for cell-to-cell communication. The condition is present from birth and is characterized by a distinctive facial appearance with a thin nose, small nostrils (hypoplastic alae nasi), and small eyes (microphthalmia or microcornea). Dental abnormalities include enamel hypoplasia, small teeth (microdontia), and early tooth decay or loss. The fingers typically show syndactyly (fusion) of the fourth and fifth fingers, and camptodactyly (permanent flexion) may also be present. Additional features can include sparse, slow-growing hair, brittle nails, and neurological manifestations such as spastic paraplegia, ataxia, bladder dysfunction, and white matter abnormalities on brain MRI. Some patients develop conductive hearing loss and cranial hyperostosis. The severity of the condition is highly variable, even within the same family. Cardiac conduction defects have also been reported in some individuals. There is currently no cure for oculodentodigital dysplasia. Treatment is symptomatic and supportive, involving a multidisciplinary approach. This may include surgical correction of syndactyly, dental interventions such as crowns and prosthetics, ophthalmologic management for glaucoma or other eye complications, and neurological care including physical therapy and antispasticity medications. Regular monitoring by specialists in ophthalmology, dentistry, neurology, and orthopedics is recommended to manage the diverse manifestations of this condition.

Common questions about Oculodentodigital dysplasia